What if you had a tool to change the genetic instructions that cause disease?
That’s what San Francisco-based Scribe Therapeutics hopes to do with its next-generation platform for gene editing.
Women with lower incomes are less likely to have knowledge of and use telehealth, according to a new survey from reproductive health nonprofit Power to Decide.
Amid a pandemic implosion, these startups showcase the strength, diversity and adaptability of America’s entrepreneurs—and provide hope for the country’s economic future.
Trump also said, “You’re going to beat it. We have the best medical equipment, we have the best medicines, all developed recently.” But is that giving too much credit to currently available treatments?